D
NeuroPace, Inc. NPCE
$16.36 -$0.14-0.85% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2025 06/30/2025 03/31/2025 12/31/2024 09/30/2024
Net Income 59.59% -31.29% -25.50% 3.71% 27.44%
Total Depreciation and Amortization 2.10% 3.25% 2.44% 0.00% 1.58%
Total Amortization of Deferred Charges 27.27% 12.24% 0.00% 4.26% -12.96%
Total Other Non-Cash Items -32.34% 32.79% 0.37% 10.22% -22.66%
Change in Net Operating Assets -179.84% 147.88% -45.55% -647.99% 255.68%
Cash from Operations 6.81% 72.12% -55.97% -178.25% 55.79%
Capital Expenditure 82.14% -354.05% 5.13% 61.00% -58.73%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- 33.33% -54.55%
Cash from Investing 82.14% -354.05% -101.89% 40.07% -56.75%
Total Debt Issued -100.23% -- -- -- --
Total Debt Repaid 100.00% -- -- -- --
Issuance of Common Stock -- -99.71% 7,440.64% -68.31% 410.50%
Repurchase of Common Stock 41.38% 99.65% -54,002.17% -35.29% 5.56%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 87.68% -109.04% 2,389.15% -70.74% 469.35%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 46.92% -130.63% 783.55% -177.23% 1,771.43%